Clinical Trial Update: GEM vs GEM+TS-1 for Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gemcitabine alone versus gemcitabine plus TS-1 for advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Japan Clinical Cancer Research Organization | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED